CJC-1295 + Ipamorelin Combined Research: GHRH/GHSR Dual Stack
The CJC-1295 + Ipamorelin combination pairs a GHRH receptor analog with a selective ghrelin receptor agonist. This guide covers the pharmacological rationale, the surrogate endpoint evidence, and the gap between endocrine markers and clinical outcomes.
Sections
Pharmacological Rationale
Mechanisms Studied for Each Component
Ready to explore our peptides?
Browse our full range of research-grade peptides with fast EU shipping.
Evidence Limits for Clinical Outcomes
Community Protocol Patterns
Storage and Regulatory Status
Stay up to date with peptide research
Get the latest research findings, product updates, and exclusive offers delivered to your inbox.
Ready to get started?
Browse our full range of research-grade peptides with fast EU shipping.